{
  "symbol": "MLAB",
  "company": "Mesa Laboratories, Inc.",
  "generated_at": "2026-06-24T07:36:50.200Z",
  "event_count": 1,
  "events": [
    {
      "type": "scout_dossier",
      "ts": "2026-06-17T18:09:09.319Z",
      "summary": "The investigation triggered on a cluster of 3 Form 4 filings in the last 14 days — but ALL THREE were S-code (sell) transactions: CFO John Sakys sold $123K (RSU tax withholding), CAO Lyndsey Crennen sold ~$12K, and SVP Brian Archbold sold ~$117K, all from RSU vest dates on June 15. These are not open-market purchases; they are routine corporate tax-withholding events with zero directional signal. The broader Form 4 record shows genuine director buys in March 2026 at $72-76 (Ladiwala, Capone, Tripeny), but no CEO/CFO/COO-level P-code (purchase) transactions anywhere in the recent window. Fundamentally MLAB is a small-cap ($524M EV) life sciences tools company with flat revenue growth (2.6% YoY), very low ROIC (~3%), and significant leverage (net debt/EBITDA ~5x). The stock has pulled back from its 52-week high of $113.99 to $94.76, down ~17%, after a Q4 FY26 earnings miss on May 27, 2026 that triggered a large sell-off. At forward P/E of ~7.7x the company appears cheap relative to life sciences tools peers — but the low multiple reflects real structural concerns (Clinical Genomics headwinds, high leverage, margin pressure). Options data is unavailable (no listed expiries), eliminating income strategy viability. Given the absence of a genuine mispricing edge, no meaningful near-term catalyst beyond earnings on August 5, and heavy insider selling at current depressed levels, there is no actionable asymmetric setup here.",
      "verdict": "no_anomaly",
      "confidence": 4,
      "tool_calls": 24,
      "walltime_min": 35,
      "debug_path": "dossiers/2026-06-17-MLAB.scout.debug.json"
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "MLAB",
    "call": "HOLD",
    "confidence": 2,
    "score": 0,
    "factors": {
      "above_200dma": "+2",
      "below_50dma": "-1",
      "momentum_up": "+1 (10.7%)",
      "rsi_neutral": "0 (37.1)",
      "recent_macd_bearish_cross": "-2 (6d ago)",
      "from_high": "0 (-15.7%)"
    },
    "summary": "HOLD (score +0) · 12-1 mom 10.7% · RSI 37.1 · above_200_only · -15.7% from high",
    "last_close": 91.97,
    "one_month_ago_close": 109.11,
    "twelve_month_ago_close": 98.59,
    "twelve_one_momentum_pct": 10.67,
    "rsi_14": 37.1,
    "ma_stack": "above_200_only",
    "from_period_high_pct": -15.72,
    "period_high": 109.13,
    "price_targets": {
      "bear": 76.39,
      "fair": 101.96,
      "bull": 130,
      "bear_return_pct": -16.9,
      "fair_return_pct": 10.9,
      "bull_return_pct": 41.4,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 94,
        "target_mean": 112,
        "target_high": 130,
        "analyst_count": 2
      }
    },
    "generated_at": "2026-06-24T07:36:50.195Z"
  }
}